Longhack Tracks

Director, Institute for Aging Research at the Albert Einstein College of Medicine,
PI: Nathan Shock Center of Excellence in the Biology of Aging
PI: Glenn Center for the Biology of Human Aging.
Co-Scientific Director of the American Federation for Aging Research
Founder and on the Board of CohBar Inc.
Chief Medical Advisor for Life Bioscience

Dr. Barzilai is a chaired Professor of Medicine and Genetics and Director of the biggest Center in the world to study the Biology of Aging and the principal investigator of the Einstein Nathan Shock Center and the Glenn center. He was the recipient of an NIH Merit Award aiming to extend the healthy life span in rodents by biological interventions. He also studies families of centenarians that have provided genetic/biological insights on the protection against aging. Several drugs are developed based, in part, on these paradigm-changing studies. He is leading the TAME (Targeting/Taming Aging with Metformin) multi-central study to prove the concept that multimorbidities of aging can be delayed in humans and change the FDA indications to allow for next-generation interventions. He is a co-founder of 2 biotech (CohBar and Lifebiosciences).

Dr. Nathan Price is Chief Scientific Officer of Thorne HealthTech (NASDAQ: THRN). Previously he was CEO of Onegevity, an AI health intelligence company that merged with Thorne prior to the IPO in 2021. In 2019, he was named as one of the 10 Emerging Leaders in Health and Medicine by the National Academy of Medicine, and in 2021 he was appointed to the Board on Life Sciences of the National Academies of Sciences, Engineering, and Medicine. He spent much of his earlier career as Professor and Associate Director of the Institute for Systems Biology (now on leave), co-director with biotechnology pioneer Lee Hood of the Hood-Price Lab for Systems Biomedicine, and is Affiliate Faculty at the University of Washington in Bioengineering and Computer Science & Engineering. He is a Camille Dreyfus Teacher-Scholar, received the 2016 Grace A. Goldsmith award for his work pioneering 'scientific wellness', was a co-founder of Arivale, and received a Healthy Longevity Catalyst Award from the National Academy of Medicine in 2020. He has co-authored more than 180 peer-reviewed scientific publications and given over 200 talks and keynotes. He also served as Chair of the NIH Study Section on Modeling and Analysis of Biological Systems (MABS).  

Kevin Perrott is a successful businessman and owner of a large snowmobile and motorcycle dealership in Canada.  After becoming a cancer survivor he decided to focus his efforts on the study of age-related disease and obtained a Ph.D. for work studying natural compounds effects on the inflammation produced by senescent cells in the lab of Judith Campisi at the Buck Institute for Research on Aging. He is Treasurer and co-founder of SENS Research Foundation and former Director of the Methuselah Foundation. He also cofounded Oisin Biotechnologies, a for-profit fighting aging through 'reprogramming' biology.  After years of working in both the for-profit and non-profit sectors to accelerate the development of interventions in aging, it became clear that a large reason for the delay is lack of involvement of the consumer and he became the Founder and CEO of OpenCures, a for-benefit enterprise that has created a platform that enables collaboration and synergies between customers and the companies who develop health technologies.